Search results
KFF Analysis Finds an Estimated 1 in 4 Medicare Beneficiaries With Obesity or Overweight Could Be...
Sierra Sun Times· 4 days agoThis change potentially allows access to Wegovy for just over 1 in 4 of the 13.7 million people on ...
Wegovy could soon treat millions of Medicare patients
Quartz· 5 days agoMillions of Americans could now be eligible for Medicare to cover their prescriptions of the popular...
FDA approval of Wegovy could give millions on Medicare access to weight-loss drug
PhillyVoice.com· 5 days agoWith this new approval, and the drug's possible dual use, millions of people on Medicare may be able...
Nearly 4 million Medicare patients with heart disease may be eligible for Wegovy coverage
Becker’s Hospital Review· 5 days agoThe FDA approved the drug to reduce the risk of heart attack and strokes in people with cardiovascular disease who are overweight or obese. Currently, Medicare is prohibited ...
Caregivers need time for themselves. One voucher program aims to help.
Democrat and Chronicle via Yahoo News· 10 hours agoMedicare could have covered a temporary stay at a nursing home, but that wasn’t an attractive...
Whatever Happened to Biden’s Public Option?
North Denver News· 3 days ago“Low-income Americans will be automatically enrolled in the public option at zero cost to them...in their party platform. The president hasn’t uttered the phrase “public option” since December ...
Q&A: Democratic candidates for 3rd Congressional District answer our questions
Oregon Capital Chronicle via Yahoo News· 4 hours agoThe retirement of longtime Oregon congressman, Rep. Earl Blumenauer, has opened up Oregon’s 3rd...
Pharma lobbying up in 2024
Politico· 5 days agoDespite the huge popularity of weight-loss drugs, Medicare is prohibited by law from covering them solely for obesity. How it could impact spending: The KFF analysis says ...
NKY’s independent pharmacies on verge of extinction
WCPO Cincinnati· 7 days agoSeither, a career pharmacist and lifelong resident of Fort Thomas, owned and operated Fort Thomas Drug Center since 2007. After 16 years, though, Seither’s business was facing economic headwinds ...
Analysis | Whatever happened to Biden’s public option?
Washington Post· 3 days agoAs we ramp up for the 2024 election, I’ve wondered why talk of the public option has disappeared....
